A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody

计划入组 200 人 · 首次发布于 2026 年 3 月 3 日

Rabies Treatment by Exposure of Patient to X-Ray

计划入组 4 人 · 首次发布于 2020 年 2 月 7 日

Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults

计划入组 72 人 · 首次发布于 2014 年 9 月 12 日

Rabies virus inactivated antigen, B(Imovax)

Rabies virus inactivated antigen, A(Rabavert)

recombinant human anti-rabies virus monoclonal antibody

HUALAN BIOLOGICAL ENGINEERING. INC.

Hualan Biological Vaccine Inc.

China

Chengdu Kanghua Biological Products Co., Ltd.

China

LakeShore Submits BLA to DRAP for PIKA Rabies Vaccine Following Positive Phase III Results

Kamada Receives FDA Approval for In-House Rabies Virus Neutralization Testing Laboratory

LakeShore Biopharma Seeks Approval for PIKA Rabies Vaccine in Pakistan After Positive Phase 3 Results